Buckley Clifford J, Arko Frank R, Lee Shirley, Mettauer Mark, Little Danny, Atkins Marvin, Manning Larry G, Patterson Donald E
Division of Vascular Surgery, Scott & White Hospital, Texas A & M University Health Science Center, Temple 76508, USA.
J Vasc Surg. 2002 Feb;35(2):316-23. doi: 10.1067/mva.2002.119755.
Underdeployment of an intravascular stent has been identified as a cause of restenosis or occlusion of a treated arterial lesion. Intravascular ultrasound (IVUS) has been shown to initially improve the anatomic and clinical stenting. The purpose of this study was to determine whether the use of IVUS increased long-term patency of this intervention.
Between March 1992 and October 1995, 71 limbs (52 patients) with symptomatic aortoiliac occlusive disease underwent balloon angioplasty with primary stenting. IVUS and arteriography were used in 49 limbs (36 patients) to evaluate stent deployment. Arteriography alone was used in 22 limbs (16 patients) to evaluate stent deployment. Patients were captured prospectively in a vascular registry and retrospectively reviewed.
Mean age of patients treated with IVUS was 61.1 plus minus 9.0 years (range, 38-85) versus 70.0 plus minus 10.1 years (range, 57-87) in patients treated without IVUS (P <.01). There was no difference between the groups with respect to preoperative comorbidities, ankle-brachial indices, or number of stents per limb. Mean follow-up for IVUS patients was 62.1 plus minus 7.3 months (range, 15-81) and 57.9 plus minus 8.7 months (range, 8-80) for patients treated without IVUS (P = not significant). In 40% (20/49) of limbs, IVUS demonstrated inadequate stent deployment at the time of the original procedure. Kaplan-Meier 3- and 6-year primary patency estimates were 100% and 100% in the IVUS group and 82% and 69%, respectively, in limbs treated without IVUS (P <.001). There have been no secondary procedures performed in limbs treated with IVUS and a 23% (5/22) secondary intervention rate in the non-IVUS group (P <.05). Overall Kaplan-Meier survival estimates at 3 and 6 years for all patients were 84% and 67%, respectively.
Balloon angioplasty and primary stenting of symptomatic aortoiliac occlusive lesions is a durable treatment option. Long-term follow-up of treated patients shows outcomes that are comparable with direct surgical intervention. IVUS significantly improved the long-term patency of iliac arterial lesions treated with balloon angioplasty and stenting by defining the appropriate angioplasty diameter endpoint and adequacy of stent deployment.
血管内支架植入不足已被确认为治疗后动脉病变再狭窄或闭塞的一个原因。血管内超声(IVUS)已被证明最初可改善解剖学和临床支架植入情况。本研究的目的是确定使用IVUS是否能提高该干预措施的长期通畅率。
在1992年3月至1995年10月期间,71条肢体(52例患者)患有症状性主-髂动脉闭塞性疾病,接受了球囊血管成形术并进行了初次支架植入。49条肢体(36例患者)使用IVUS和血管造影来评估支架植入情况。22条肢体(16例患者)仅使用血管造影来评估支架植入情况。患者被前瞻性纳入血管登记处并进行回顾性审查。
接受IVUS治疗的患者平均年龄为61.1±9.0岁(范围38 - 85岁),而未接受IVUS治疗的患者平均年龄为70.0±10.1岁(范围57 - 87岁)(P <.01)。两组在术前合并症、踝肱指数或每条肢体的支架数量方面无差异。接受IVUS治疗的患者平均随访时间为62.1±7.3个月(范围15 - 81个月),未接受IVUS治疗的患者平均随访时间为57.9±8.7个月(范围8 - 80个月)(P = 无显著性差异)。在40%(20/49)的肢体中,IVUS显示在最初手术时支架植入不足。IVUS组的Kaplan-Meier 3年和6年主要通畅率估计分别为100%和100%,而未接受IVUS治疗的肢体分别为82%和69%(P <.001)。接受IVUS治疗的肢体未进行二次手术,非IVUS组的二次干预率为23%(5/22)(P <.05)。所有患者的总体Kaplan-Meier 3年和6年生存率估计分别为84%和67%。
症状性主-髂动脉闭塞性病变的球囊血管成形术和初次支架植入是一种持久的治疗选择。对治疗患者的长期随访显示结果与直接手术干预相当。IVUS通过确定合适的血管成形术直径终点和支架植入的充分性,显著提高了经球囊血管成形术和支架植入治疗的髂动脉病变的长期通畅率。